MSP Recovery Price to Free Cash Flow Ratio 2020-2025 | MSPR

MSP Recovery price to free cash flow ratio from 2020 to 2025. Price to free cash flow ratio can be defined as

MSP Recovery Price to Free Cash Flow Ratio 2020-2025 | MSPR

MSP Recovery price to free cash flow ratio from 2020 to 2025. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$47.5B
Hims & Hers Health (HIMS)$12.9B
Doximity (DOCS)$11.4B
Tempus AI (TEM)$11.2B
IRhythm Technologies (IRTC)$4.3B
Inspire Medical Systems (INSP)$3.8B
Hinge Health (HNGE)$3.6B
Privia Health (PRVA)$2.4B
10x Genomics (TXG)$1.7B
Schrodinger (SDGR)$1.6B
Phreesia (PHR)$1.6B
Azenta (AZTA)$1.6B
Enovis (ENOV)$1.6B
Clover Health Investments (CLOV)$1.5B
Omnicell (OMCL)$1.3B
Evolent Health (EVH)$1.2B
Claritev (CTEV)$652M
Fulgent Genetics (FLGT)$559M
Standard BioTools (LAB)$532M
Veradigm (MDRX)$503M
Butterfly Network (BFLY)$487M
Talkspace (TALK)$421M
TruBridge (TBRG)$353M
Outset Medical (OM)$328M
Health Catalyst (HCAT)$270M
Nyxoah SA (NYXH)$258M
SOPHiA GENETICS SA (SOPH)$240M
CapsoVision (CV)$185M
Zepp Health (ZEPP)$161M
KORU Medical Systems (KRMD)$160M